Temporal changes and regional differences in treatment uptake of hepatitis <scp>C</scp> therapy in <scp>EuroSIDA</scp>
Journal: HIV Medicine
Year: 2013

Objectives All HIV /hepatitis C virus ( HCV )‐coinfected patients with chronic HCV infection and ≥ F 2 fibrosis should be considered for HCV therapy. This study aimed to determine the rate of HCV treatment uptake among coinfected patients in Europe. Methods EuroSIDA patients with viraemic HCV infection were included in the study. Poisson regression was used to identify temporal changes and regional differences in HCV treatment uptake. Results A total of 1984 patients were included in the study,